Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

Expression of the human antimicrobial peptide β-defensin-1 is repressed by the EGFR-ERK-MYC axis in colonic epithelial cells.

Bonamy C, Sechet E, Amiot A, Alam A, Mourez M, Fraisse L, Sansonetti PJ, Sperandio B.

Sci Rep. 2018 Dec 21;8(1):18043. doi: 10.1038/s41598-018-36387-z.

2.

Dose de-escalation to adalimumab 40 mg every three weeks in patients with inflammatory bowel disease-A multicenter, retrospective, observational study.

Pouillon L, Lamoureux A, Pineton de Chambrun G, Vuitton L, Pariente B, Zallot C, Dufour G, Fumery M, Baumann C, Amiot A, Nancey S, Rousseau H, Peyrin-Biroulet L.

Dig Liver Dis. 2019 Feb;51(2):236-241. doi: 10.1016/j.dld.2018.10.022. Epub 2018 Nov 8.

PMID:
30502230
3.

Gastrointestinal involvement in Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective case series.

Gendreau S, Amiot A, Le Baleur Y, Charpy C, Wolkenstein P, Chosidow O, Mekontso Dessap A, Ingen-Housz-Oro S, de Prost N.

Br J Dermatol. 2018 Nov 15. doi: 10.1111/bjd.17428. [Epub ahead of print] No abstract available.

PMID:
30430542
4.

Anti-TNF therapy for genital fistulas in female patients with Crohn's disease: a nationwide study from the Groupe d'Etude Thérapeutique des Affections Inflammatoires du tube Digestif (GETAID).

Le Baut G, Peyrin-Biroulet L, Bouguen G, Gornet JM, Stefanescu C, Amiot A, Laharie D, Altwegg R, Fumery M, Trang C, Vuitton L, Simon M, Gilletta de Saint Joseph C, Nahon S, Caillo L, Del Tedesco E, Plastaras L, Aubourg A, Pineton de Chambrun G, Seksik P, Viennot S.

Aliment Pharmacol Ther. 2018 Oct;48(8):831-838. doi: 10.1111/apt.14946. Epub 2018 Sep 7.

PMID:
30194687
5.

Risk of serious infection in healthcare workers with inflammatory bowel disease: a case-control study of the Groupe d'Etude Thérapeutique des Affections Inflammatoires du tube Digestif (GETAID).

Gagnière C, Bourrier A, Seksik P, Gornet JM, DeWit O, Nancey S, Altwegg R, Abitbol V, Laharie D, Reenaers C, Buisson A, Pariente B, Viennot S, Vuitton L, Stefanescu C, Marteau P, Bouguen G, Cosnes J, Amiot A; GETAID INFOPRO study group.

Aliment Pharmacol Ther. 2018 Oct;48(7):713-722. doi: 10.1111/apt.14926. Epub 2018 Aug 2.

PMID:
30069921
6.

Ustekinumab treatment for neutrophilic dermatoses associated with Crohn's disease: A multicenter retrospective study.

de Risi-Pugliese T, Seksik P, Bouaziz JD, Chasset F, Moguelet P, Gornet JM, Bourrier A, Amiot A, Beaugerie L, Francès C, Guégan S; Ustekinumab–Crohn's Disease–Neutrophilic Dermatosis Study Group.

J Am Acad Dermatol. 2019 Mar;80(3):781-784. doi: 10.1016/j.jaad.2018.06.065. Epub 2018 Jul 10. No abstract available.

PMID:
30003991
7.

Chemical composition and antifungal activity of plant extracts traditionally used in organic and biodynamic farming.

Andreu V, Levert A, Amiot A, Cousin A, Aveline N, Bertrand C.

Environ Sci Pollut Res Int. 2018 Oct;25(30):29971-29982. doi: 10.1007/s11356-018-1320-z. Epub 2018 Mar 7.

PMID:
29516419
8.

2017 WSES guidelines for the management of iatrogenic colonoscopy perforation.

de'Angelis N, Di Saverio S, Chiara O, Sartelli M, Martínez-Pérez A, Patrizi F, Weber DG, Ansaloni L, Biffl W, Ben-Ishay O, Bala M, Brunetti F, Gaiani F, Abdalla S, Amiot A, Bahouth H, Bianchi G, Casanova D, Coccolini F, Coimbra R, de'Angelis GL, De Simone B, Fraga GP, Genova P, Ivatury R, Kashuk JL, Kirkpatrick AW, Le Baleur Y, Machado F, Machain GM, Maier RV, Chichom-Mefire A, Memeo R, Mesquita C, Salamea Molina JC, Mutignani M, Manzano-Núñez R, Ordoñez C, Peitzman AB, Pereira BM, Picetti E, Pisano M, Puyana JC, Rizoli S, Siddiqui M, Sobhani I, Ten Broek RP, Zorcolo L, Carra MC, Kluger Y, Catena F.

World J Emerg Surg. 2018 Jan 24;13:5. doi: 10.1186/s13017-018-0162-9. eCollection 2018. Review.

9.

Long-term efficacy and safety of ustekinumab in 122 refractory Crohn's disease patients: a multicentre experience.

Wils P, Bouhnik Y, Michetti P, Flourie B, Brixi H, Bourrier A, Allez M, Duclos B, Serrero M, Buisson A, Amiot A, Fumery M, Roblin X, Peyrin-Biroulet L, Filippi J, Bouguen G, Abitbol V, Coffin B, Simon M, Laharie D, Pariente B; Groupe d'Etude Thérapeutique des Affections Inflammatoires du Tube Digestif (GETAID).

Aliment Pharmacol Ther. 2018 Mar;47(5):588-595. doi: 10.1111/apt.14487. Epub 2018 Jan 8.

PMID:
29315694
10.

Impact of vedolizumab therapy on extra-intestinal manifestations in patients with inflammatory bowel disease: a multicentre cohort study nested in the OBSERV-IBD cohort.

Tadbiri S, Peyrin-Biroulet L, Serrero M, Filippi J, Pariente B, Roblin X, Buisson A, Stefanescu C, Trang-Poisson C, Altwegg R, Marteau P, Vaysse T, Bourrier A, Nancey S, Laharie D, Allez M, Savoye G, Gilletta C, Gagniere C, Vuitton L, Viennot S, Aubourg A, Pelletier AL, Bouguen G, Abitbol V, Fumery M, Claudepierre P, Bouhnik Y, Amiot A; GETAID OBSERV-IBD study group.

Aliment Pharmacol Ther. 2018 Feb;47(4):485-493. doi: 10.1111/apt.14419. Epub 2017 Dec 18.

PMID:
29250803
11.

Patients' comorbidities reduce the clinical value of emergency colonoscopy: results of a retrospective cohort study.

Cremone C, Esch A, Gagniere C, Fugazza A, Mesli F, Levy M, Amiot A, Laurent A, LeBaleur Y, Hemery F, De'Angelis N, Brunetti F, Sobhani I.

Endosc Int Open. 2017 Nov;5(11):E1119-E1127. doi: 10.1055/s-0043-118001. Epub 2017 Nov 8.

12.

Long-term course of precancerous lesions arising in patients with gastric MALT lymphoma.

Rentien AL, Lévy M, Copie-Bergman C, Gagniere C, Dupuis J, Le Baleur Y, Belhadj K, Sobhani I, Haioun C, Delchier JC, Amiot A.

Dig Liver Dis. 2018 Feb;50(2):181-188. doi: 10.1016/j.dld.2017.10.014. Epub 2017 Oct 27.

PMID:
29102522
13.

Efficacy and safety of golimumab in Crohn's disease: a French national retrospective study.

Martineau C, Flourié B, Wils P, Vaysse T, Altwegg R, Buisson A, Amiot A, Pineton de Chambrun G, Abitbol V, Fumery M, Hébuterne X, Viennot S, Laharie D, Beaugerie L, Nancey S, Sokol H; Goli-Crohn Study Group.

Aliment Pharmacol Ther. 2017 Dec;46(11-12):1077-1084. doi: 10.1111/apt.14371. Epub 2017 Oct 13.

PMID:
29027693
14.

Outcomes 7 Years After Infliximab Withdrawal for Patients With Crohn's Disease in Sustained Remission.

Reenaers C, Mary JY, Nachury M, Bouhnik Y, Laharie D, Allez M, Fumery M, Amiot A, Savoye G, Altwegg R, Devos M, Malamut G, Bourreille A, Flourie B, Marteau P, Vuitton L, Coffin B, Viennot S, Lambert J, Colombel JF, Louis E; Groupe d'Etude Therapeutique des Affections Inflammatoires du tube Digestif.

Clin Gastroenterol Hepatol. 2018 Feb;16(2):234-243.e2. doi: 10.1016/j.cgh.2017.09.061. Epub 2017 Oct 7.

15.

Endoscopic training: A nationwide survey of French fellows in gastroenterology.

Amiot A, Conroy G, Le Baleur Y, Winkler J, Palazzo M, Treton X.

Clin Res Hepatol Gastroenterol. 2018 Apr;42(2):160-167. doi: 10.1016/j.clinre.2017.08.005. Epub 2017 Sep 18.

PMID:
28927657
16.

Features of Autoimmune Pancreatitis Associated With Inflammatory Bowel Diseases.

Lorenzo D, Maire F, Stefanescu C, Gornet JM, Seksik P, Serrero M, Bournet B, Marteau P, Amiot A, Laharie D, Trang C, Coffin B, Bellaiche G, Cadiot G, Reenaers C, Racine A, Viennot S, Pauwels A, Bouguen G, Savoye G, Pelletier AL, Pineton de Chambrun G, Lahmek P, Nahon S, Abitbol V; GETAID-AIP study group.

Clin Gastroenterol Hepatol. 2018 Jan;16(1):59-67. doi: 10.1016/j.cgh.2017.07.033. Epub 2017 Aug 4.

PMID:
28782667
17.

One-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multicentre cohort study.

Amiot A, Serrero M, Peyrin-Biroulet L, Filippi J, Pariente B, Roblin X, Buisson A, Stefanescu C, Trang-Poisson C, Altwegg R, Marteau P, Vaysse T, Bourrier A, Nancey S, Laharie D, Allez M, Savoye G, Moreau J, Vuitton L, Viennot S, Aubourg A, Pelletier AL, Bouguen G, Abitbol V, Gagniere C, Bouhnik Y; OBSERV-IBD study group and the GETAID.

Aliment Pharmacol Ther. 2017 Aug;46(3):310-321. doi: 10.1111/apt.14167. Epub 2017 Jun 8.

18.

Risk of Rectal Neoplasia after Colectomy and Ileorectal Anastomosis for Ulcerative Colitis.

Uzzan M, Kirchgesner J, Oubaya N, Amiot A, Gornet JM, Seksik P, Nancey S, Cotte E, Allez M, Boschetti G, Laharie D, de Angelis N, Nachury M, Pelletier AL, Abitbol V, Fumery M, Brouquet A, Buisson A, Altwegg R, Cosnes J, Panis Y, Treton X.

J Crohns Colitis. 2017 Aug 1;11(8):930-935. doi: 10.1093/ecco-jcc/jjx027.

PMID:
28333202
19.

Intragastric migration of a mesentericoportal polytetrafluoroethylene jump graft after liver transplantation.

Esposito F, Lim C, Salloum C, Osseis M, Baranes L, Amiot A, Compagnon P, Azoulay D.

Liver Transpl. 2017 May;23(5):696-697. doi: 10.1002/lt.24747. Epub 2017 Apr 11. No abstract available.

20.

Laparoscopic vs. open surgery for the treatment of iatrogenic colonoscopic perforations: a systematic review and meta-analysis.

Martínez-Pérez A, de'Angelis N, Brunetti F, Le Baleur Y, Payá-Llorente C, Memeo R, Gaiani F, Manfredi M, Gavriilidis P, Nervi G, Coccolini F, Amiot A, Sobhani I, Catena F, de'Angelis GL.

World J Emerg Surg. 2017 Feb 6;12:8. doi: 10.1186/s13017-017-0121-x. eCollection 2017. Review.

21.

Second primary malignancies in patients treated for gastric mucosa-associated lymphoid tissue lymphoma.

Amiot A, Jooste V, Gagniere C, Lévy M, Copie-Bergman C, Dupuis J, Le Baleur Y, Belhadj K, Sobhani I, Haioun C, Bouvier AM, Delchier JC.

Leuk Lymphoma. 2017 Sep;58(9):1-11. doi: 10.1080/10428194.2017.1283033. Epub 2017 Jan 31.

PMID:
28140708
22.

Robotic Versus Laparoscopic Gastric Resection for Primary Gastrointestinal Stromal Tumors >5 cm: A Size-Matched and Location-Matched Comparison.

de'Angelis N, Genova P, Amiot A, Charpy C, Disabato M, Belgaumkar AP, Chahrour A, Legou F, Azoulay D, Brunetti F.

Surg Laparosc Endosc Percutan Tech. 2017 Feb;27(1):65-71. doi: 10.1097/SLE.0000000000000371.

PMID:
28079762
23.

Autoimmune cytopenias associated with inflammatory bowel diseases: Insights from a multicenter retrospective cohort.

Uzzan M, Galicier L, Gornet JM, Oksenhendler E, Fieschi C, Allez M, Bouhnik Y, Kirchgesner J, Boutboul D, Treton X, Gérard L, Mahévas M, Cosnes J, Amiot A.

Dig Liver Dis. 2017 Apr;49(4):397-404. doi: 10.1016/j.dld.2016.12.006. Epub 2016 Dec 23.

PMID:
28063954
24.

Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximab.

Laharie D, Bourreille A, Branche J, Allez M, Bouhnik Y, Filippi J, Zerbib F, Savoye G, Vuitton L, Moreau J, Amiot A, Cosnes J, Ricart E, Dewit O, Lopez-Sanroman A, Fumery M, Carbonnel F, Bommelaer G, Coffin B, Roblin X, van Assche G, Esteve M, Farkkila M, Gisbert JP, Marteau P, Nahon S, de Vos M, Lambert J, Mary JY, Louis E; Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives.

Gut. 2018 Feb;67(2):237-243. doi: 10.1136/gutjnl-2016-313060. Epub 2017 Jan 4.

25.

Rate and Predictors of Mucosal Healing in Ulcerative Colitis Treated with Thiopurines: Results of a Multicentric Cohort Study.

Prieux-Klotz C, Nahon S, Amiot A, Sinayoko L, Galéano-Cassaz C, Chaussade S, Coriat R, Lahmek P, Abitbol V.

Dig Dis Sci. 2017 Feb;62(2):473-480. doi: 10.1007/s10620-016-4374-0. Epub 2016 Nov 16.

PMID:
27853898
26.

Effectiveness and Safety of Vedolizumab Induction Therapy for Patients With Inflammatory Bowel Disease.

Amiot A, Grimaud JC, Peyrin-Biroulet L, Filippi J, Pariente B, Roblin X, Buisson A, Stefanescu C, Trang-Poisson C, Altwegg R, Marteau P, Vaysse T, Bourrier A, Nancey S, Laharie D, Allez M, Savoye G, Moreau J, Gagniere C, Vuitton L, Viennot S, Aubourg A, Pelletier AL, Bouguen G, Abitbol V, Bouhnik Y; Observatory on Efficacy and of Vedolizumab in Patients With Inflammatory Bowel Disease Study Group; Groupe d'Etude Therapeutique des Affections Inflammatoires du tube Digestif.

Clin Gastroenterol Hepatol. 2016 Nov;14(11):1593-1601.e2. doi: 10.1016/j.cgh.2016.02.016. Epub 2016 Feb 22.

PMID:
26917043
27.

Long-term Follow-up After Ileorectal Anastomosis for Ulcerative Colitis: A GETAID/GETAID Chirurgie Multicenter Retrospective Cohort of 343 Patients.

Uzzan M, Cosnes J, Amiot A, Gornet JM, Seksik P, Cotte E, Tiret E, Panis Y, Treton X.

Ann Surg. 2017 Dec;266(6):1029-1034. doi: 10.1097/SLA.0000000000002022.

PMID:
27655238
28.

Negative Screening Does Not Rule Out the Risk of Tuberculosis in Patients with Inflammatory Bowel Disease Undergoing Anti-TNF Treatment: A Descriptive Study on the GETAID Cohort.

Abitbol Y, Laharie D, Cosnes J, Allez M, Nancey S, Amiot A, Aubourg A, Fumery M, Altwegg R, Michetti P, Chanteloup E, Seksik P, Baudry C, Flamant M, Bouguen G, Stefanescu C, Bourrier A, Bommelaer G, Dib N, Bigard MA, Viennot S, Hébuterne X, Gornet JM, Marteau P, Bouhnik Y, Abitbol V, Nahon S; GETAID.

J Crohns Colitis. 2016 Oct;10(10):1179-85. doi: 10.1093/ecco-jcc/jjw129. Epub 2016 Jul 11.

PMID:
27402916
29.

Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge.

Fischer N, Sechet E, Friedman R, Amiot A, Sobhani I, Nigro G, Sansonetti PJ, Sperandio B.

Proc Natl Acad Sci U S A. 2016 May 24;113(21):E2993-3001. doi: 10.1073/pnas.1605997113. Epub 2016 May 9.

30.

Risk of Incident Cancer in Inflammatory Bowel Disease Patients Starting Anti-TNF Therapy While Having Recent Malignancy.

Poullenot F, Seksik P, Beaugerie L, Amiot A, Nachury M, Abitbol V, Stefanescu C, Reenaers C, Fumery M, Pelletier AL, Nancey S, Peyrin-Biroulet L, Bourreille A, Hébuterne X, Brixi H, Savoye G, Lourenço N, Altwegg R, Buisson A, Cazelles-Boudier C, Racine A, Vergniol J, Laharie D; le GETAID.

Inflamm Bowel Dis. 2016 Jun;22(6):1362-9. doi: 10.1097/MIB.0000000000000741.

PMID:
26919458
31.

Rescue therapy with bismuth-containing quadruple therapy in patients infected with metronidazole-resistant Helicobacter pylori strains.

Muller N, Amiot A, Le Thuaut A, Bastuji-Garin S, Deforges L, Delchier JC.

Clin Res Hepatol Gastroenterol. 2016 Sep;40(4):517-24. doi: 10.1016/j.clinre.2015.12.012. Epub 2016 Feb 2.

PMID:
26850363
32.

Editorial: what can be done when infliximab stops working in ulcerative colitis? Authors' reply.

Amiot A, Stefanescu C, Bouhnik Y.

Aliment Pharmacol Ther. 2016 Jan;43(1):165. doi: 10.1111/apt.13439. No abstract available.

33.

Subcutaneous Ustekinumab Provides Clinical Benefit for Two-Thirds of Patients With Crohn's Disease Refractory to Anti-Tumor Necrosis Factor Agents.

Wils P, Bouhnik Y, Michetti P, Flourie B, Brixi H, Bourrier A, Allez M, Duclos B, Grimaud JC, Buisson A, Amiot A, Fumery M, Roblin X, Peyrin-Biroulet L, Filippi J, Bouguen G, Abitbol V, Coffin B, Simon M, Laharie D, Pariente B; Groupe d'Etude Thérapeutique des Affections Inflammatoires du Tube Digestif.

Clin Gastroenterol Hepatol. 2016 Feb;14(2):242-50.e1-2. doi: 10.1016/j.cgh.2015.09.018. Epub 2015 Sep 30.

34.

The outcome of infliximab dose doubling in 157 patients with ulcerative colitis after loss of response to infliximab.

Dumitrescu G, Amiot A, Seksik P, Baudry C, Stefanescu C, Gagniere C, Allez M, Cosnes J, Bouhnik Y.

Aliment Pharmacol Ther. 2015 Nov;42(10):1192-9. doi: 10.1111/apt.13393. Epub 2015 Sep 10.

35.

(1)H NMR Spectroscopy of Fecal Extracts Enables Detection of Advanced Colorectal Neoplasia.

Amiot A, Dona AC, Wijeyesekera A, Tournigand C, Baumgaertner I, Lebaleur Y, Sobhani I, Holmes E.

J Proteome Res. 2015 Sep 4;14(9):3871-81. doi: 10.1021/acs.jproteome.5b00277. Epub 2015 Aug 7.

PMID:
26211820
36.

Therapeutic drug monitoring is predictive of loss of response after de-escalation of infliximab therapy in patients with inflammatory bowel disease in clinical remission.

Amiot A, Hulin A, Belhassan M, Andre C, Gagniere C, Le Baleur Y, Farcet JP, Delchier JC, Hüe S.

Clin Res Hepatol Gastroenterol. 2016 Feb;40(1):90-8. doi: 10.1016/j.clinre.2015.05.019. Epub 2015 Jun 29.

PMID:
26138132
37.

Detection of Dysplasia or Cancer in 3.5% of Patients With Inflammatory Bowel Disease and Colonic Strictures.

Fumery M, Pineton de Chambrun G, Stefanescu C, Buisson A, Bressenot A, Beaugerie L, Amiot A, Altwegg R, Savoye G, Abitbol V, Bouguen G, Simon M, Duffas JP, Hébuterne X, Nancey S, Roblin X, Leteurtre E, Bommelaer G, Lefevre JH, Brunetti F, Guillon F, Bouhnik Y, Peyrin-Biroulet L.

Clin Gastroenterol Hepatol. 2015 Oct;13(10):1770-5. doi: 10.1016/j.cgh.2015.04.185. Epub 2015 May 19.

38.

Current, new and future biological agents on the horizon for the treatment of inflammatory bowel diseases.

Amiot A, Peyrin-Biroulet L.

Therap Adv Gastroenterol. 2015 Mar;8(2):66-82. doi: 10.1177/1756283X14558193. Review.

39.

[Protein-losing enteropathy].

Amiot A.

Rev Med Interne. 2015 Jul;36(7):467-73. doi: 10.1016/j.revmed.2014.12.001. Epub 2015 Jan 21. Review. French.

PMID:
25618488
40.

Benefit of infliximab reintroduction after successive failure of infliximab and adalimumab in Crohn's disease.

Gagniere C, Beaugerie L, Pariente B, Seksik P, Amiot A, Abitbol V, Allez M, Cosnes J, Sokol H.

J Crohns Colitis. 2015 Apr;9(4):349-55. doi: 10.1093/ecco-jcc/jju024. Epub 2014 Dec 28.

PMID:
25547977
41.

Potential of fecal microbiota for early-stage detection of colorectal cancer.

Zeller G, Tap J, Voigt AY, Sunagawa S, Kultima JR, Costea PI, Amiot A, Böhm J, Brunetti F, Habermann N, Hercog R, Koch M, Luciani A, Mende DR, Schneider MA, Schrotz-King P, Tournigand C, Tran Van Nhieu J, Yamada T, Zimmermann J, Benes V, Kloor M, Ulrich CM, von Knebel Doeberitz M, Sobhani I, Bork P.

Mol Syst Biol. 2014 Nov 28;10:766. doi: 10.15252/msb.20145645.

42.

Long-term outcome of enterocutaneous fistula in patients with Crohn's disease treated with anti-TNF therapy: a cohort study from the GETAID.

Amiot A, Setakhr V, Seksik P, Allez M, Treton X, De Vos M, Laharie D, Colombel JF, Abitbol V, Reimund JM, Moreau J, Veyrac M, Flourié B, Cosnes J, Lemann M, Bouhnik Y.

Am J Gastroenterol. 2014 Sep;109(9):1443-9. doi: 10.1038/ajg.2014.183. Epub 2014 Aug 5.

PMID:
25091063
43.

The detection of the methylated Wif-1 gene is more accurate than a fecal occult blood test for colorectal cancer screening.

Amiot A, Mansour H, Baumgaertner I, Delchier JC, Tournigand C, Furet JP, Carrau JP, Canoui-Poitrine F, Sobhani I; CRC group of Val De Marne.

PLoS One. 2014 Jul 15;9(7):e99233. doi: 10.1371/journal.pone.0099233. eCollection 2014.

44.

Factors associated with pregnancy outcome in anti-TNF treated women with inflammatory bowel disease.

Seirafi M, de Vroey B, Amiot A, Seksik P, Roblin X, Allez M, Peyrin-Biroulet L, Marteau P, Cadiot G, Laharie D, Boureille A, De Vos M, Savoye G, Rahier JF, Carbonnel F, Bonaz B, Colombel JF, Bouhnik Y.

Aliment Pharmacol Ther. 2014 Aug;40(4):363-73. doi: 10.1111/apt.12833. Epub 2014 Jun 30.

45.

Infliximab as a bridge to remission maintained by antimetabolite therapy in Crohn's disease: A retrospective study.

Chauvin A, Le Thuaut A, Belhassan M, Le Baleur Y, Mesli F, Bastuji-Garin S, Delchier JC, Amiot A.

Dig Liver Dis. 2014 Aug;46(8):695-700. doi: 10.1016/j.dld.2014.04.012. Epub 2014 Jun 2.

PMID:
24893686
46.

[Dermatitis herpetiformis antibodies: What the dermatologist must know].

Ingen-Housz-Oro S, Amiot A, Ortonne N, Hüe S.

Ann Dermatol Venereol. 2014 May;141(5):387-91. doi: 10.1016/j.annder.2014.03.013. Epub 2014 Apr 8. French. No abstract available.

PMID:
24835656
47.

Upper gastrointestinal obstruction due to trichobezoar.

Bousfiha N, Derieux S, Amiot A, Cherif R.

Presse Med. 2014 Sep;43(9):1008-9. doi: 10.1016/j.lpm.2013.12.013. Epub 2014 Apr 16. No abstract available.

PMID:
24742617
48.

Rituximab, alkylating agents or combination therapy for gastric mucosa-associated lymphoid tissue lymphoma: a monocentric non-randomised observational study.

Amiot A, Lévy M, Copie-Bergman C, Dupuis J, Szablewski V, Le Baleur Y, Baia M, Belhadj K, Sobhani I, Leroy K, Haioun C, Delchier JC.

Aliment Pharmacol Ther. 2014 Mar;39(6):619-28. doi: 10.1111/apt.12635. Epub 2014 Jan 27.

49.

European evidence based consensus for endoscopy in inflammatory bowel disease.

Annese V, Daperno M, Rutter MD, Amiot A, Bossuyt P, East J, Ferrante M, Götz M, Katsanos KH, Kießlich R, Ordás I, Repici A, Rosa B, Sebastian S, Kucharzik T, Eliakim R; European Crohn's and Colitis Organisation.

J Crohns Colitis. 2013 Dec;7(12):982-1018. doi: 10.1016/j.crohns.2013.09.016. Epub 2013 Nov 1. No abstract available.

50.

Non-transplantation surgical approach for chronic intestinal pseudo-obstruction: analysis of 63 adult consecutive cases.

Sabbagh C, Amiot A, Maggiori L, Corcos O, Joly F, Panis Y.

Neurogastroenterol Motil. 2013 Oct;25(10):e680-6. doi: 10.1111/nmo.12191. Epub 2013 Jul 29.

PMID:
23895212

Supplemental Content

Support Center